Galapagos NV - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GLPG Nasdaq 2836 www.glpg.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Galapagos NV

Third Arc Bio Announces $52M Series A Extension to Expand Oncology and Immunology & Inflammation Portfolio - Feb 4th, 2026 5:00 am
Galapagos (ENXTAM:GLPG) Valuation Check After Mixed Results And Ongoing Net Loss - Jan 10th, 2026 4:12 pm
Galapagos Announces Board Decision to Initiate Wind-Down of Cell Therapy Activities - Jan 5th, 2026 2:01 pm
Galapagos Announces Topline Results from Two Phase 3-Enabling Studies with Selective TYK2 Inhibitor GLPG3667 in Dermatomyositis and Systemic Lupus Erythematosus - Dec 18th, 2025 2:01 pm
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025 - Dec 7th, 2025 11:30 pm
Galapagos Receives Transparency Notifications from Bank of America - Nov 25th, 2025 11:30 pm
Is Galapagos (ENXTAM:GLPG) Fairly Valued After Recent Share Price Uptick? - Nov 11th, 2025 12:11 am
Galapagos NV (GLPG) Q3 2025 Earnings Call Highlights: Navigating Strategic Shifts Amidst ... - Nov 6th, 2025 12:06 pm
Galapagos Reports Nine Months 2025 Financial Results and Provides Business Update - Nov 5th, 2025 2:01 pm
Galapagos to Present New Data from Cell Therapy Program at ASH 2025 - Nov 3rd, 2025 2:01 pm
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development - Oct 30th, 2025 2:01 pm
Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors - Oct 23rd, 2025 2:01 pm
Why Galapagos (ENXTAM:GLPG) Is Down 7.9% After Exiting Cell Therapy and Cutting Jobs – And What's Next - Oct 23rd, 2025 10:09 am
Galapagos to shutter cell therapy unit - Oct 22nd, 2025 6:41 am
Sector Update: Health Care Stocks Advance Late Afternoon - Oct 21st, 2025 1:41 pm
Investors Parse Earnings Reports With US Equity Futures Flat Tuesday Pre-Bell - Oct 21st, 2025 6:09 am
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation - Oct 20th, 2025 11:30 pm
Galapagos Announces Appointment of Fred Blakeslee as General Counsel - Oct 16th, 2025 2:01 pm
Galapagos Provides Update on Strategic Alternatives for Its Cell Therapy Business - Oct 1st, 2025 2:01 pm
Galapagos (AMS:GLPG) Is In A Good Position To Deliver On Growth Plans - Sep 29th, 2025 3:35 am